Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30

$0.68−0.07 (-8.81%)

Close on Nov 12, 2026Market cap $22.22MP/E –Yield –

Celularity EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Celularity's EPS for the twelve months ending Jun 30, 2026 was -$1.70. For fiscal 2025 it was -$3.59. The highest annual figure on record is $0.95 in fiscal 2022.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$3.59	–
FY2024	Dec 31, 2024	-$2.64	–
FY2023	Dec 31, 2023	-$11.02	-1260.0%
FY2022	Dec 31, 2022	$0.95	–
FY2021	Dec 31, 2021	-$14.90	–
FY2020	Dec 31, 2020	-$113.10	-34030.0%
FY2019	Dec 31, 2019	$0.33	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$0.02	–
Q1 FY2026	Mar 31, 2026	$0.02	–
Q4 FY2025	Dec 31, 2025	-$0.86	–
Q3 FY2025	Sep 30, 2025	-$0.88	–
Q2 FY2025	Jun 30, 2025	-$1.02	–
Q1 FY2025	Mar 31, 2025	-$0.84	–
Q4 FY2024	Dec 31, 2024	-$0.60	-220.0%
Q3 FY2024	Sep 30, 2024	-$0.73	–
Q2 FY2024	Jun 30, 2024	-$0.30	–
Q1 FY2024	Mar 31, 2024	-$1.03	–
Q4 FY2023	Dec 31, 2023	$0.50	+66.7%
Q3 FY2023	Sep 30, 2023	-$4.98	-255.6%
Q2 FY2023	Jun 30, 2023	-$2.72	–
Q1 FY2023	Mar 31, 2023	-$4.12	-203.0%
Q3 FY2022	Sep 30, 2022	$0.30	–
Q2 FY2022	Jun 30, 2022	$3.20	–
Q1 FY2022	Mar 31, 2022	-$4.80	–
Q3 FY2021	Sep 30, 2021	$4.00	–
Q2 FY2021	Jun 30, 2021	-$26.90	-20275.1%
Q1 FY2021	Mar 31, 2021	-$34.00	–
Q3 FY2020	Sep 30, 2020	-$25.20	–
Q2 FY2020	Jun 30, 2020	$0.00	–
Q1 FY2020	Mar 31, 2020	$0.13	–
Q3 FY2019	Sep 30, 2019	-$0.03	–
Q2 FY2019	Jun 30, 2019	$0.00	–
Q1 FY2019	Mar 31, 2019	$0.00	–